Previous Chapter Chapter 22: Emerging European Markets for Transcatheter Embolization and Occlusion Devices Next Chapter

In: SAGE Sourcebook of Modern Biomedical Devices: Business Environments in a Global Market

Chapter 22: Emerging European Markets for Transcatheter Embolization and Occlusion Devices

  • Citations
  • Add to My List
  • Text Size

Emerging European Markets for Transcatheter Embolization and Occlusion Devices
Emerging European markets for transcatheter embolization and occlusion devices
Millennium Research Group, A Decision Resources, Inc. Company

The Europe II transcatheter embolization and occlusion (TEO) market, consisting of Benelux (Belgium, the Netherlands, and Luxembourg), Spain, Switzerland, and the rest of Europe (ROE; Austria, Denmark, Finland, Norway, Portugal, and Sweden), was valued at over $55 million in 2005 and will increase at a compound annual growth rate (CAGR) of almost 9% over the forecast period, as displayed in Exhibit 3.21. The adoption of new and innovative TEO technologies in interventional neuroradiology (INR), peripheral vascular (PV), and interventional cardiology (IC) procedures—such as endovascular cerebral aneurysm coils, microspheres, and heart defect closure devices—will be the major drivers of revenue growth ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website